Promoter collection, Human ETS1 promoter
Alternative name | U3027-3 |
---|---|
Clone info. | PCR amplified human ETS1 promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 128523650 to 128522176(NC_000011.10 ); relatively +63908 to +65383, where +1 corresponds to 1 nt of NM_001143820.2; relatively -1340 to +135, where +1 corresponds to 1 nt of NM_005238.4. |
Comment | PCR cloning, forward primer:atttgctgtgggaaatctgc; reverse primer: aggggaagttggcactttg. |
Vector backbone | pGL4.10 [Luc2] (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) genomic DNA |
Depositor|Developer | DNA Bank, | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07819 | pGL4-phETS1 | DNA solution |
Materials & Methods section:
The pGL4-phETS1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07819). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07819_A5F4.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: pGL4-4174F Sequence file: RDB07819_A5F4a.seq |
---|
>07819_07819_A5F4_2_pGL4-4174F_A01_01.ab1 1 CTGGGTCAGA CATTTCTCTG GCCTAACTGG CCGGTACCTG AGCTCGCTAG CCTCGAGGAT 61 ATTTGCTGTG GGAAATCTGC AAATTACTAA GGCTTCAAGG GCACAAAACT GGGATTAGAT 121 GAAGGTAAGC CTGTGTGTCA AAACTTACCA GAGGCAGAGG TTACAGTTAC AGTCAAATGC 181 TGGGAGTTCA AATGTGCTTA GAAATCAGGA AACATTAAAA ATAGCTTTCT CTGAGATTGC 241 TCAGGAAGAT TTATGTTTAA TCTTTCTGTT AATCAAAGAT GGAGCTCAGT GCCTGGTTCT 301 AGCTATGTAT TTAGATATAT ACATGTACTG GTTGATTTGT TAATTAGGAC AAACTATCTC 361 TATTACAACC AATGTATTAG TGGCAAACCA TGAATTATTC GGGTTCATTT TGTTTTATCT 421 CTAGTGTTGG GGGTTCCCAA ATGGAACAGA AACTGTGCAT TGTGATTCTG TCATGGCTGC 481 CAATGATGTA CTCCAGAAAT TCAAAACCAC AGAGCCTCTG CATCACTTTT TTGGTGGCGG 541 TCGTGGGAGG GTTGTTAGTT TTATCTAAAA GAGGAGAGTC TGTGAAAGGA AAGACAAAGC 601 TTTGGCCAAT GGTGACATAA TTAGAGGAAC AGAATAATTA GAAATAAATC ATAACTTCCC 661 CTTCAACCCA ACCACTGCTG GAGGTAAATT GGAAGCTTAC GGAAGCTCAT GGCTGGGTTC 721 TAGTTTGGGG TCCCGTTCTG GACTCCCCTG CCAACGCAGG AGCATTACAT GGGTGGGCTC 781 TGAAAAACTG AAGCCTCCTT CAGAAACACA CGCCCTGACT CAAGATCCGG CTGGAGTCCA 841 ATACTCCTAA AGCCCTTTGA GGACACGGGC TCACGAATCC CCTGCGCCTG CCTGCACGCT 901 CGCCTTCATC CACATGCCTC ACGTCCTGTG TGTCAGTCTT TGTGAAATGA ATGATGTACA 961 CGCACTTGGA AAACTATGCT GCTACTGGGA GGGGGGCGAG AGCGGGTGAC CCAAGCCCTC 1021 AAGGAATTGC GTGAGGATCA AGACGGACTT TCCGGAAACC GCTGAGCCGT CTGTGCACCA 1081 GCCTGCACAC CCGCTCCCTG GCCGTTTCCC CGACCCCCCG // |
Primer: pGL4-136R Sequence file: RDB07819_A5F4b.seq |
>07819_07819_A5F4_2_pGL4-136R_B01_04.ab1 1 GCTAAGCTTT TGGCATCTTC ATGGTGGCTT TACCAACAGT ACCGGATTGC CAAGCTTGGC 61 CGCCGAGGCC AGATCTTGAT AGGGGAAGTT GGCACTTTGC GGCGAAGTGA GCGCGCTCGG 121 GTCCCAGCCT CGCCCGCGCC GCGCCCGCTC CTCCTGCCCG GCCCTCGCCC GCTCCCTCCT 181 CTCCGCCGGC GGCTGCCTCG TTCGCTCTCG ATCTCCCGGC CGCTCTCCCT CCCTCTCGCC 241 CTCCCGCGCT CTCCCCTCCT CTTTAGGGCG TTTCTCGCGG CGCCGCGTCT CGGCCGCTGG 301 GTCCGCGCGC CCTGGGCCGG GCGATGTCCG CTTGGGGGAG CGAGGGGCGG GGCGTCGGGG 361 CAGGGCGGGG AGCCGGGGGC GGGGCCGAGC ACCGCGGCCA ATCTCCGCCC GCGGCCCAAA 421 GCGAAAGGAA GGGCTGGCGA GCGCGGGGCC GGGCCGCGAC CGCGGAGGAG CAGTGCGTGG 481 AGCCCCGGGC CTCGGAGCCC AGGCTGGGGC GGGAAGGGCC GGGAGCGGGT GTGCAGGCTG 541 GGTGCACAGG CCGCCTCCAC CGTTTCGGGA AAGTCCGTCT GATTCTCCAC GCATTCTTGA 601 GGGCTTGGTC ACCCGCTCTC GCCCCCTCCC AGTAGCAGCA TAGTTTTCCA AGTGCGTGTA 661 CATCATTCAT TCACAAAGAC TGACACACAG GACGTGAGGC ATGTGGATGA AGGCGAGCGT 721 GCAGGCAGGC GCAGGGGATT CGTGAGCCCG TGTCCTCAAA GGGCTTTAGG AGTATTGGAC 781 TCCAGCCGGA TCTTGAGTCA GGGCGTGTGT TTCTGAAGGA GGCTTCAGTT TTTCAGAGCC 841 CACCCATGTA ATGCTCCTGC GTTGGCAGGG GAGTCCAGAA CGGGACCCCA AACTAGAACC 901 CAGCCATGAG CTTCCGTAAG CTTCCAATTT ACCTCCAGCA GTGGTTGGGG TTGAAAGGGG 961 AAGTTATGAT TATTTCTAAA TTATTCTGTT CCTCTAATAT GTCACCATTG GCCAAAGCTT 1021 GTCCTTCTTC ACAGACTCCT CTTCTTTAGA TAACTACAAC CATCCCACGA CGCACGAAAA 1081 GTGATGCAGA GCTCTGGTGG ATCG // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content